McDonnell Boehnen Hulbert & Berghoff LLP partner Kevin Noonan, Ph.D. is quoted in a September 6, 2019 Law360.com article entitled, “Fed. Circ. Clouds Landscape For Medical Treatment Patents.” The Federal Circuit has held that many methods of treating disease are patent-eligible, but a recent decision that withholding treatment is ineligible has left attorneys questioning exactly where the line is drawn and whether some medical advances now cannot be patented. View the article
